|
IARS2 expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | 7.541400E-01 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
1.886620E-01 |
| Normal-vs-Stage2 |
4.794600E-01 |
| Normal-vs-Stage3 |
9.956600E-01 |
| Normal-vs-Stage4 |
2.039200E-01 |
| Stage1-vs-Stage2 |
1.081010E-01 |
| Stage1-vs-Stage3 |
2.642000E-01 |
| Stage1-vs-Stage4 |
5.956100E-02 |
| Stage2-vs-Stage3 |
5.021800E-01 |
| Stage2-vs-Stage4 |
5.480800E-01 |
| Stage3-vs-Stage4 |
2.249200E-01 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
4.124800E-01 |
| Normal-vs-AfricanAmerican |
2.311000E-01 |
| Normal-vs-Asian |
6.660400E-01 |
| Caucasian-vs-AfricanAmerican |
8.297700E-02 |
| Caucasian-vs-Asian |
3.647800E-01 |
| AfricanAmerican-vs-Asian |
3.742400E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
7.535200E-01 |
| Normal-vs-Female |
7.991000E-01 |
| Male-vs-Female |
8.829800E-01 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
1.464810E-01 |
| Normal-vs-Age(41-60Yrs) |
5.196600E-01 |
| Normal-vs-Age(61-80Yrs) |
1.125770E-01 |
| Normal-vs-Age(81-100Yrs) |
6.777200E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
4.194600E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
1.054380E-02 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
4.383000E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
4.323900E-02 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
6.443800E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
7.174200E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
4.688600E-01 |
| Classical-VS-Follicular |
2.436100E-02 |
| Classical-VS-Other |
1.302770E-01 |
| Classical-VS-Normal |
5.723600E-01 |
| Tall-VS-Follicular |
4.555700E-02 |
| Tall-VS-Other |
6.061900E-02 |
| Tall-VS-Normal |
2.831000E-01 |
| Follicular-VS-Other |
4.584200E-01 |
| Follicular-VS-Normal |
9.820200E-02 |
| Other-VS-Normal |
1.918400E-01 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
1.955240E-01 |
| Normal-vs-N1 |
2.240800E-01 |
| N0-vs-N1 |
6.084800E-01 |
|
|
